Aleksandra Siekierska

During her FWO post-doctoral training at KU Leuven, Belgium (Department of Pharmaceutical and Pharmacological Sciences) her main scientific focus was to model human genetic diseases (in particular epilepsy) in zebrafish larvae to understand their pathogenesis and screen for novel medications. As a senior scientist, she managed and further improved the laboratory’s zebrafish platform for CNS drug discovery and toxicity assessment. She made an effective contribution to the development of novel therapeutics by co-developing and testing design strategy to diminish protein aggregation (patent co-inventor). Aleksandra is an author on over 20 peer-reviewed publications of which some in leading journals like Nature Communications, Nature Genetics, Cell, and Neurology. In the beginning of 2022, she joined the VirusBank Platform to set-up the translational research platform for the discovery of therapeutical solutions for infectious diseases.